Navigation Links
GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging

Lamictal, an antiepileptic drug, is one of the several prescription drugs that has encountered the problem of dispensing errors.

Dispensing errors are often a result of miscommunication, which can include poor hand writing of the prescription and confusion between drugs with similar names.//

It is important for patients with epilepsy not to have an interruption in treatment because it could lead to consequence such as status epilepticus.

Conversely, those patients that do not have epilepsy could be placed at unnecessary risk of adverse events, including serious rash, if they are mistakenly given Lamictal.

The most common dispensing errors have been between Lamisil(R), an antifungal tablet and Lamictal.In these instances, either Lamisil was substituted for Lamictal or Lamictal was substituted for Lamisil.

GlaxoSmithKline announced that it has substantially changed the appearance of container labeling and packaging in an effort to reduce the potential for dispensing errors involving its antiepileptic drug Lamictal(lamotrigene).

As a result, GlaxoSmithKline has worked closely with the Food and Drug Administration(FDA) in an effort to educate pharmacists and physicians about the potential for Lamictal dispensing errors.

The container label change is a part of this effort.These efforts reinforce the importance of clear communication between physicians, phamacists and patients.


'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline To Cultivate Non-Smoking Environment
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. FDA Mislead On Asthma Drug By GlaxoSmithKline
4. GlaxoSmithKline Defends Its Products
5. GlaxoSmithKline launches diabetes and cancer drugs
6. Generic Products Compete With GlaxoSmithKline
7. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
8. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
9. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
10. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
11. GlaxoSmithKline Signs Outsourcing Deal With TCS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology: